Export

EN
FR
Isoniazid + pyrazinamide + rifampicin
Essential medicine status
General description
Isoniazid + pyrazinamid + rifampicin is a medication used to treat tuberculosis.
INN
Isoniazid + pyrazinamide + rifampicin
Medicine type
Chemical agent
Antibiotic groups
EML status history
First added in 1997 (TRS 882) for Tuberculosis
Removed in 2009 (TRS 958) for Tuberculosis
Added in 2017 (TRS 1006) for Tuberculosis
Therapeutic equivalent for
Recommendations
Section
Antituberculosis medicines
  • Oral > Solid: 50 mg + 150 mg + 75 mg tablet (dispersible)
Indications